Muscarinic receptor-dependent activation of phospholipase C in human fetal central nervous system organotypic tissue culture

Jorge N. Larocca, Alicia G. Rodriguez-Gabin, William K. Rashbaum, Karen M. Weidenheim, William D. Lyman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The coupling of muscarinic-cholinergic receptors (mAchR) with the phospholipase C (PLC) second messenger system has been demonstrated in central nervous system (CNS) tissue of many animal species. However, little information exists regarding this association in the developing human CNS. Due to the suggested role of acetylcholine in the regulation of development and differentiation of neural cells, the knowledge of these relationships during human fetal development acquires singular importance. Because of this, we examined the cholinergic stimulation of PLC in human fetal CNS organotypic tissue cultures. Agonist treatment of cultures, in the presence of lithium, resulted in a 4-6-fold increase in inositol phosphates formation. This increase was caused principally by the formation of inositol phosphate (IP). However, kinetic studies demonstrated that the levels of IP2, IP3 and IP4 also increased rapidly after stimulation reaching maximum levels before IT. These results support the hypothesis that muscarinic receptor activation results in an increase in the hydrolysis of PIP2. The inositol phosphate formation was dependent on agonist concentration. The obtained EC50 values were approximately 57 ± 15 μM for carbachol, 8 ± 2 μM for acetylcholine and 49 ± 15 μM for oxotremorine. The agonist-dependent formation of inositol phosphates was inhibited by the muscarinic antagonists atropine and pirenzepine. Pirenzepine inhibited carbachol stimulation with high affinity (Ki = 2.90 ± 1.15 nM), indicating that PLC activation is the result of activation of the m1 subtype of muscarinic receptors. Treatment of cultures with pertussis toxin did not result in inhibition of agonist-dependent activation of PLC. This result suggests that the m1 muscarinic receptor is coupled to PLC through Gq.

Original languageEnglish (US)
Pages (from-to)135-141
Number of pages7
JournalBrain Research
Volume701
Issue number1-2
DOIs
StatePublished - Dec 1 1995

Fingerprint

Type C Phospholipases
Muscarinic Receptors
Inositol Phosphates
Central Nervous System
Muscarinic M1 Receptors
Pirenzepine
Carbachol
Acetylcholine
Nerve Tissue
Muscarinic Antagonists
Pertussis Toxin
Human Development
Second Messenger Systems
Cholinergic Receptors
Fetal Development
Atropine
Lithium
Cholinergic Agents
Cell Differentiation
Hydrolysis

Keywords

  • Fetal CNS
  • Human neurodevelopment
  • Neural cell differentiation
  • Signal transduction

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Muscarinic receptor-dependent activation of phospholipase C in human fetal central nervous system organotypic tissue culture. / Larocca, Jorge N.; Rodriguez-Gabin, Alicia G.; Rashbaum, William K.; Weidenheim, Karen M.; Lyman, William D.

In: Brain Research, Vol. 701, No. 1-2, 01.12.1995, p. 135-141.

Research output: Contribution to journalArticle

Larocca, Jorge N. ; Rodriguez-Gabin, Alicia G. ; Rashbaum, William K. ; Weidenheim, Karen M. ; Lyman, William D. / Muscarinic receptor-dependent activation of phospholipase C in human fetal central nervous system organotypic tissue culture. In: Brain Research. 1995 ; Vol. 701, No. 1-2. pp. 135-141.
@article{09b75d1c74164a44afacc150dc67db73,
title = "Muscarinic receptor-dependent activation of phospholipase C in human fetal central nervous system organotypic tissue culture",
abstract = "The coupling of muscarinic-cholinergic receptors (mAchR) with the phospholipase C (PLC) second messenger system has been demonstrated in central nervous system (CNS) tissue of many animal species. However, little information exists regarding this association in the developing human CNS. Due to the suggested role of acetylcholine in the regulation of development and differentiation of neural cells, the knowledge of these relationships during human fetal development acquires singular importance. Because of this, we examined the cholinergic stimulation of PLC in human fetal CNS organotypic tissue cultures. Agonist treatment of cultures, in the presence of lithium, resulted in a 4-6-fold increase in inositol phosphates formation. This increase was caused principally by the formation of inositol phosphate (IP). However, kinetic studies demonstrated that the levels of IP2, IP3 and IP4 also increased rapidly after stimulation reaching maximum levels before IT. These results support the hypothesis that muscarinic receptor activation results in an increase in the hydrolysis of PIP2. The inositol phosphate formation was dependent on agonist concentration. The obtained EC50 values were approximately 57 ± 15 μM for carbachol, 8 ± 2 μM for acetylcholine and 49 ± 15 μM for oxotremorine. The agonist-dependent formation of inositol phosphates was inhibited by the muscarinic antagonists atropine and pirenzepine. Pirenzepine inhibited carbachol stimulation with high affinity (Ki = 2.90 ± 1.15 nM), indicating that PLC activation is the result of activation of the m1 subtype of muscarinic receptors. Treatment of cultures with pertussis toxin did not result in inhibition of agonist-dependent activation of PLC. This result suggests that the m1 muscarinic receptor is coupled to PLC through Gq.",
keywords = "Fetal CNS, Human neurodevelopment, Neural cell differentiation, Signal transduction",
author = "Larocca, {Jorge N.} and Rodriguez-Gabin, {Alicia G.} and Rashbaum, {William K.} and Weidenheim, {Karen M.} and Lyman, {William D.}",
year = "1995",
month = "12",
day = "1",
doi = "10.1016/0006-8993(95)00986-3",
language = "English (US)",
volume = "701",
pages = "135--141",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Muscarinic receptor-dependent activation of phospholipase C in human fetal central nervous system organotypic tissue culture

AU - Larocca, Jorge N.

AU - Rodriguez-Gabin, Alicia G.

AU - Rashbaum, William K.

AU - Weidenheim, Karen M.

AU - Lyman, William D.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - The coupling of muscarinic-cholinergic receptors (mAchR) with the phospholipase C (PLC) second messenger system has been demonstrated in central nervous system (CNS) tissue of many animal species. However, little information exists regarding this association in the developing human CNS. Due to the suggested role of acetylcholine in the regulation of development and differentiation of neural cells, the knowledge of these relationships during human fetal development acquires singular importance. Because of this, we examined the cholinergic stimulation of PLC in human fetal CNS organotypic tissue cultures. Agonist treatment of cultures, in the presence of lithium, resulted in a 4-6-fold increase in inositol phosphates formation. This increase was caused principally by the formation of inositol phosphate (IP). However, kinetic studies demonstrated that the levels of IP2, IP3 and IP4 also increased rapidly after stimulation reaching maximum levels before IT. These results support the hypothesis that muscarinic receptor activation results in an increase in the hydrolysis of PIP2. The inositol phosphate formation was dependent on agonist concentration. The obtained EC50 values were approximately 57 ± 15 μM for carbachol, 8 ± 2 μM for acetylcholine and 49 ± 15 μM for oxotremorine. The agonist-dependent formation of inositol phosphates was inhibited by the muscarinic antagonists atropine and pirenzepine. Pirenzepine inhibited carbachol stimulation with high affinity (Ki = 2.90 ± 1.15 nM), indicating that PLC activation is the result of activation of the m1 subtype of muscarinic receptors. Treatment of cultures with pertussis toxin did not result in inhibition of agonist-dependent activation of PLC. This result suggests that the m1 muscarinic receptor is coupled to PLC through Gq.

AB - The coupling of muscarinic-cholinergic receptors (mAchR) with the phospholipase C (PLC) second messenger system has been demonstrated in central nervous system (CNS) tissue of many animal species. However, little information exists regarding this association in the developing human CNS. Due to the suggested role of acetylcholine in the regulation of development and differentiation of neural cells, the knowledge of these relationships during human fetal development acquires singular importance. Because of this, we examined the cholinergic stimulation of PLC in human fetal CNS organotypic tissue cultures. Agonist treatment of cultures, in the presence of lithium, resulted in a 4-6-fold increase in inositol phosphates formation. This increase was caused principally by the formation of inositol phosphate (IP). However, kinetic studies demonstrated that the levels of IP2, IP3 and IP4 also increased rapidly after stimulation reaching maximum levels before IT. These results support the hypothesis that muscarinic receptor activation results in an increase in the hydrolysis of PIP2. The inositol phosphate formation was dependent on agonist concentration. The obtained EC50 values were approximately 57 ± 15 μM for carbachol, 8 ± 2 μM for acetylcholine and 49 ± 15 μM for oxotremorine. The agonist-dependent formation of inositol phosphates was inhibited by the muscarinic antagonists atropine and pirenzepine. Pirenzepine inhibited carbachol stimulation with high affinity (Ki = 2.90 ± 1.15 nM), indicating that PLC activation is the result of activation of the m1 subtype of muscarinic receptors. Treatment of cultures with pertussis toxin did not result in inhibition of agonist-dependent activation of PLC. This result suggests that the m1 muscarinic receptor is coupled to PLC through Gq.

KW - Fetal CNS

KW - Human neurodevelopment

KW - Neural cell differentiation

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0028803180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028803180&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)00986-3

DO - 10.1016/0006-8993(95)00986-3

M3 - Article

VL - 701

SP - 135

EP - 141

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -